novo nordisk glp-1 weight loss Ozempic for everyone? Inside Nordisk's big plans for its hit drug GLP-1 boom lifts Novo Nordisk,

Those numbers would seem to be sufficient to drive a raft of attempts to limit the individual and societal costs

10.1016/j.biopha.2016.10.036 196 ZhaoJ.LeiH

The nausea, vomiting, and diarrhea commonly associated with semaglutide therapy can lead to reduced fluid intake or increased fluid loss, potentially resulting in dry mouth (xerostomia)

Changes in pH and ionic environment can alter amino acid side-chain charge, hydrogen bonding, peptide folding or association, and hydrophobic interactions

Why GLP-1s change taste Medications like Wegovy and Zepbound weren't specifically designed to change the way food tastes

European Respiratory Society